
Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation
Keywords: RAR, retinoic acid receptor; CTCL, cutaneous T cell lymphoma; HDAC, histone deacetylase; RXR, retinoid X receptorsRetinoic acid receptor; Cutaneous T cell lymphoma; Histone acetylation; DNA methylation